DIA391.36-5.21 -1.31%
SPX5,282.70+7.00 0.13%
IXIC16,286.45-20.71 -0.13%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·04/17/2025 12:09:34
Listen to the news

Gainers

  • Channel Therapeutics (AMEX:CHRO) stock increased by 86.5% to $2.34 during Thursday's pre-market session. The market value of their outstanding shares is at $14.1 million.
  • Sharps Technology (NASDAQ:STSS) stock rose 34.33% to $0.04.
  • InnovAge Holding (NASDAQ:INNV) stock increased by 19.71% to $3.4. The market value of their outstanding shares is at $459.8 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock increased by 19.35% to $7.16. The market value of their outstanding shares is at $147.4 million.
  • Sunshine Biopharma (NASDAQ:SBFM) shares rose 14.75% to $1.4. The market value of their outstanding shares is at $5.0 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares rose 14.25% to $1.13. The company's market cap stands at $15.5 million.

Losers

  • Forian (NASDAQ:FORA) shares fell 36.0% to $1.26 during Thursday's pre-market session. The market value of their outstanding shares is at $39.3 million.
  • TNF Pharmaceuticals (NASDAQ:TNFA) shares decreased by 23.9% to $0.19. As per the news, the Q4 earnings report came out 4 days ago.
  • Sophia Genetics (NASDAQ:SOPH) stock declined by 19.58% to $2.26. The company's market cap stands at $150.1 million.
  • UnitedHealth Group (NYSE:UNH) stock declined by 19.33% to $472.0. The company's market cap stands at $431.7 billion. As per the press release, Q1 earnings came out today.
  • Tourmaline Bio (NASDAQ:TRML) shares declined by 15.98% to $12.2. The company's market cap stands at $313.3 million.
  • enVVeno Medical (NASDAQ:NVNO) shares declined by 15.13% to $2.02. The company's market cap stands at $35.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.